MIF and breast cancer: Further, these MEK1 expression studies were consistent with the results obtained with the small-molecule inhibitors of MEK1 and confirmed a key antiapoptotic role of a MEK1-dependent pathway in MCF-7 breast cancer cells undergoing 4-OHT and/or MIF treatments.